Search Results - "Glassman, Deanna"

Clinical implications of tumor‐based next‐generation sequencing in high‐grade epithelial ovarian cancer by Foster, Katherine I., Shaw, Kenna R. M., Jin, Jeff, Westin, Shannon N., Yap, Timothy A., Glassman, Deanna M., Jazaeri, Amir A., Rauh‐Hain, Jose A., Lee, Sanghoon, Fellman, Bryan M., Ju, Zhenlin, Liu, Yuexin, Fleming, Nicole D., Sood, Anil K.

“…Background Tumor‐based next‐generation sequencing is used inconsistently as a tool to tailor treatment of ovarian cancer, yet beyond detection of somatic BRCA1…”
Get full text

Endothelial p130cas confers resistance to anti-angiogenesis therapy by Wen, Yunfei, Chelariu-Raicu, Anca, Umamaheswaran, Sujanitha, Nick, Alpa M., Stur, Elaine, Hanjra, Pahul, Jiang, Dahai, Jennings, Nicholas B., Chen, Xiuhui, Corvigno, Sara, Glassman, Deanna, Lopez-Berestein, Gabriel, Liu, Jinsong, Hung, Mien-Chie, Sood, Anil K.

Get full text

Endothelial p130cas confers resistance to anti-angiogenesis therapy by Wen, Yunfei, Chelariu-Raicu, Anca, Umamaheswaran, Sujanitha, Nick, Alpa M., Stur, Elaine, Hanjra, Pahul, Jiang, Dahai, Jennings, Nicholas B., Chen, Xiuhui, Corvigno, Sara, Glassman, Deanna, Lopez-Berestein, Gabriel, Liu, Jinsong, Hung, Mien-Chie, Sood, Anil K.

“…Anti-angiogenic therapies, such as anti-VEGF antibodies (AVAs), have shown promise in clinical settings. However, adaptive resistance to such therapies occurs…”
Get full text

Posterior-scleritis: Case report of an uncommon immune-related adverse event in the treatment of advanced endometrial cancer by Ing, Brandon I., Kuhl, Derek, Glassman, Deanna, Johnson, Cynae A., Patel, Shrina, Jazaeri, Amir A.

“…•Immune checkpoint inhibitors are being expanded for use in the treatment of advanced endometrial cancer.•Rare immune-related adverse events may be more common…”
Get full text

Mechanism and rational combinations with GP‐2250, a novel oxathiazine derivative, in ovarian cancer by Kim, Mark S., Glassman, Deanna, Handley, Katelyn F., Lankenau Ahumada, Adrian, Jennings, Nicholas B., Bayraktar, Emine, Foster, Katherine, Joseph, Robiya, Lee, Sanghoon, Coleman, Robert L., Sood, Anil K.

“…Background GP‐2250, a novel analog of taurultam (TRLT), has emerged as a potent anti‐neoplastic drug; however, the mechanisms underlying its effects are not…”
Get full text

Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer by Glassman, Deanna, Kim, Mark S., Spradlin, Meredith, Badal, Sunil, Taki, Mana, Bhattacharya, Pratip, Dutta, Prasanta, Kingsley, Charles V., Foster, Katherine I., Animasahun, Olamide, Jeon, Jin Heon, Achreja, Abhinav, Jayaraman, Anusha, Kumar, Praveen, Nenwani, Minal, Wuchu, Fulei, Bayraktar, Emine, Wu, Yutuan, Stur, Elaine, Mangala, Lingegowda, Lee, Sanghoon, Yap, Timothy A., Westin, Shannon N., Eberlin, Livia S., Nagrath, Deepak, Sood, Anil K.

“…Despite modest clinical improvement with anti-vascular endothelial growth factor antibody (AVA) therapy in ovarian cancer, adaptive resistance is ubiquitous…”
Get full text

Diagnostic and treatment considerations for synchronous cancer of the ovary and endometrium by Glassman, Deanna, Rauh-Hain, Jose Alejandro, Tandon, Nidhi, Fattahi, Nikoo

Get more information

Does cancer appearance reflect genetic status? The relationship between the gross appearance of high-grade serous ovarian cancer and BRCA mutation status by Glassman, Deanna, Handley, Katelyn, Asare, Amma, Foster, Katherine, Sims, Travis, Fleming, Nicole, Celestino, Joseph, Lee, Sanghoon, Sood, Anil

Get full text

Innovation in gynecologic oncology fellowship training: Rethinking the research year (1207) by Boruta, David, Glassman, Deanna, Alpard, Scott, Checka, Cristina, Bartlett, Rush, Van Truskett, Van, Jennings, Ashley, Price, Mellie

Get full text

Pixel Pioneers: A novel artificial intelligence modeling tool for laparoscopic assessment of ovarian carcinoma by Asare, Amma, Ma, Xiaotian, Hsu, Yu-Chun, Glassman, Deanna, Handley, Katelyn, Foster, Katherine, Fleming, Nicole, Westin, Shannon, Jazaeri, Amir, Bhattacharya, Pratip, Zhang, Kai, Jiang, Xiaoqian, Sood, Anil

Get full text

Tumor reductive surgery and survival outcomes in recurrent adult type granulosa cell tumors of the ovary (152) by Handley, Katelyn, Glassman, Deanna, Legarreta, Alejandra Flores, Frumovitz, Michael, Lawson, Barrett, Gershenson, David, Sood, Anil, Ramondetta, Lois, Hillman, Robert

Get full text

Impact of cytoreductive surgery on survival outcomes for recurrent adult-type granulosa cell tumors of the ovary by How, Jeffrey, Flores Legarreta, Alejandra, Fellman, Bryan M., Handley, Katelyn, Foster, Katherine, Glassman, Deanna, Lawson, Barrett, Ramondetta, Lois M., Gershenson, David Marc, Sood, Anil K, Hillman, Robert Tyler

“…5573 Background: Adult-type granulosa cell tumor of the ovary (aGCT) is a rare tumor that often relapses and the optimal management strategy is not known…”
Get full text

Clinical outcomes with leuprolide acetate for the treatment of recurrent granulosa cell tumor (160) by Foster, Katherine, Legarreta, Alejandra Flores, Kamat, Rhea, Handley, Katelyn, Glassman, Deanna, How, Jeffrey, Westin, Shannon, Ramondetta, Lois, Gershenson, David, Sood, Anil, Hillman, Robert

Get full text

Partners in crime: The relationship between the ovarian tumor microbiome and venous thromboembolism (2264) by Asare, Amma, Glassman, Deanna, Ajami, Nadim, Wong, Matthew, Foster, Katherine, Corvigno, Sara, Afshar-Kharghan, Vahid, Fleming, Nicole, Lee, Sanghoon, Wargo, Jennifer, Sood, Anil

Get full text

CDK4/6 inhibitors potently inhibit cell viability in pre-clinical models of adult-type ovarian granulosa cell tumors by Brodsky, Allison, Welte, Thomas, Legarreta, Alejandra Flores, Handley, Katelyn, Glassman, Deanna, Vuttaradhi, Veena, Khlebus, Eleonora, How, Jeffrey, Lawson, Barrett, Frumovitz, Michael, Westin, Shannon, Ramondetta, Lois, Gershenson, David, Sood, Anil, Cobb, Lauren, Hillman, Robert

Get full text

Reading the signs: Radiographic characterization of morphologic subtypes of high-grade serous ovarian cancer (141) by Foster, Katherine, Handley, Katelyn, Bhosale, Priya, Glassman, Deanna, Sims, Travis, Javadi, Sanaz, Palmquist, Sarah, Saleh, Mohammed, Fellman, Bryan, Fleming, Nicole, Sood, Anil

Get full text

How to train your robot: Artificial intelligence predicts treatment response in ovarian cancer (069) by Glassman, Deanna, Handley, Katelyn, Fleming, Nicole, Westin, Shannon, Jazaeri, Amir, Rauh-Hain, Jose, Foster, Katherine, Bhattacharya, Pratip, Shams, Shayan, Sood, Anil

Get full text

Anatomic patterns of recurrence in adult type granulosa cell tumors of the ovary (161) by Zhang, Yingao, Handley, Katelyn, Glassman, Deanna, Legarreta, Alejandra Flores, Frumovitz, Michael, Lawson, Barrett, Gershenson, David, Sood, Anil, Ramondetta, Lois, Hillman, Robert

Get full text

Is Sentinel Lymph Node Sampling Indicated in Endometrial Intraepithelial Neoplasia? [37F] by Emerson, Jenna, Glassman, Deanna, Quddus, M Ruhul, Mathews, Cara A

“…INTRODUCTION:We sought to identify uterine risk factors and frequency for which lymph node sampling was indicated among women undergoing hysterectomy for a…”
Get full text

Messages from the genome: the genetic makeup of ovarian cancer and the risk of venous thromboembolism by Glassman, Deanna, Lee, Sanghoon, Zhao, Li, Ivan, Cristina, Rangel, Kelly, Zhang, Jianhua, Futreal, P. Andrew, Fleming, Nicole, Afshar-Kharghan, Vahid, Sood, Anil

“…It is well known that patients with cancer and a concurrent venous thromboembolism (VTE) have poorer oncologic outcomes. Despite the fact that 25-40% of…”
Get full text